SIDDI Act of 2024

HR 8570, the SIDDI Act of 2024, establishes a federal grant program to reimburse pharmacies for providing safe in-home drug disposal systems and medication safety education to specific patients. It targets patients receiving opioid prescriptions who are at risk of overdose, including those with first-time, short-term acute, or dosage-changed prescriptions. The bill requires states to apply for grants to implement demonstration programs, detailing pharmacy reimbursement rates, patient selection criteria, and electronic claim processes for the disposal systems and 5-minute safety education sessions. Funding of $56 million over five fiscal years (2025-2029) will support up to five states in administering these programs, with strict reporting requirements on participation rates and program effectiveness.